Post-Authorisation Safety Studies (PASS)
Date: | 21-Sep-15 to 22-Sep-15 |
Location: | TRYP Berlin Mitte / Berlin / Germany |
Category: | Healthcare & Pharmaceuticals Conferences & Trade Fairs |
A PASS may be initiated, managed or financed by a marketing authorisation holder voluntarily, or pursuant to an obligation imposed by a competent authority. A PASS can be an integral part of drug approval and continuous development. A PASS needs multi-departmental input in a company and at regulatory approval level. It is the key to applying the right methodology for the correctly identified problem.
This course offers insight into GVP Module VIII on PASS. It delivers insight into (pharmaco-)epidemiological methodology for non-interventional studies, and the concept of multi-departmental collaboration for the development and conduct of a PASS. There will be a chance to practice with real life examples.
What participants from previous course say:
"PASS preparation was a good exercise!!!"
What You Will Learn
GVP Module VIII: Post-authorisation safety studies
Principles of Pharmacoepidemiology
Study types
Study sources
Methodology
Protocol development
Who Should Attend
This course is aimed at professionals working within:
Clinical Safety and Pharmacovigilance
Research and Development
Medical Affairs and Medical Marketing
Regulatory Affairs
Comparative Effectiveness, Health Technology Assessment, Evidence-based Medicine
Level: Intermediate
Learning Objectives
At the conclusion of this course, participants should be able to:
To understand the concept of PASS
To discuss the proper study methodology and setting in relation to the safety topic(s) of interest
To deal with the latest EMA/CHMP/PRAC and EnCePP requirements for PASS studies
Participants will complete a knowledge check at the end of the course and will be provided with feedback to ensure learning objectives are attained.
This course offers insight into GVP Module VIII on PASS. It delivers insight into (pharmaco-)epidemiological methodology for non-interventional studies, and the concept of multi-departmental collaboration for the development and conduct of a PASS. There will be a chance to practice with real life examples.
What participants from previous course say:
"PASS preparation was a good exercise!!!"
What You Will Learn
GVP Module VIII: Post-authorisation safety studies
Principles of Pharmacoepidemiology
Study types
Study sources
Methodology
Protocol development
Who Should Attend
This course is aimed at professionals working within:
Clinical Safety and Pharmacovigilance
Research and Development
Medical Affairs and Medical Marketing
Regulatory Affairs
Comparative Effectiveness, Health Technology Assessment, Evidence-based Medicine
Level: Intermediate
Learning Objectives
At the conclusion of this course, participants should be able to:
To understand the concept of PASS
To discuss the proper study methodology and setting in relation to the safety topic(s) of interest
To deal with the latest EMA/CHMP/PRAC and EnCePP requirements for PASS studies
Participants will complete a knowledge check at the end of the course and will be provided with feedback to ensure learning objectives are attained.
Exhibitors
Gro Laier, Jan Petracek
EIN News
provides powerful, real-time media monitoring, news aggregation & syndication services. Read the latest news about this topic. See:
- Autism News Today
- Brain Cancer News Today
- Breast Cancer News Today
- Breastfeeding News Today
- Conferences & Trade Shows Today
- Dental Industry Today
- Dietary Supplements News Today
- H1N1 News Today
- H7N9 Bird Flu News Today
- Health Insurance Exchanges News
- Healthcare Industry Today
- Healthcare Reform News Today
- Home Birth News Today
- Lung Cancer News Today
- MERS News Today
- Malaria News Today
- Marijuana News Today
- Mesothelioma News Today
- Pharmaceutical Industry Today
- Planned Parenthood News Today
- Prostate Cancer News Today
- SARS News Today
- Wellness News Today